Bed Bath & Beyond director exercises 26,873 RSUs
Bed Bath & Beyond director Barclay Corbus reported several equity compensation moves.
Rhea-AI Filing Summary
Bed Bath & Beyond director Barclay Corbus reported several equity compensation moves. On May 15, 2026, he exercised 26,873 restricted stock units into common shares, bringing his direct common stock holdings to 105,047 shares.
He also received a new grant of 35,181 restricted stock units on May 14, 2026, which will vest at the close of business on May 14, 2027. In addition, he holds 7,816 common stock warrants originally issued on October 7, 2025, each allowing purchase of one common share at an exercise price of $15.50 per warrant through October 7, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 26,873 | $0.00 | $0.00 |
| Exercise | Common Stock | 26,873 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 35,181 | $0.00 | $0.00 |
| Grant/Award | Common Stock Warrant | 7,816 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
- F2. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
- F3. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
Key Figures
Key Terms
restricted stock unit financial
common stock warrant financial
exercise price financial
Section 16 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Barclay Corbus report for BBBY?
What are the details of the new restricted stock units granted to Barclay Corbus at BBBY?
What are the terms of Barclay Corbus’s Bed Bath & Beyond common stock warrants?
AI-generated analysis. How Rhea-AI works. Not financial advice.